Found: 2
Select item for more details and to access through your institution.
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01653-0
- By:
- Publication type:
- Article
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 15, p. 16142, doi. 10.1002/cam4.6272
- By:
- Publication type:
- Article